GRETCHEN TRENARY: Open Payments
NPI 1811552748 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 7 payments from 5 companies in 2025. Trend: 2023 $34 · 2024 $0 · 2025 $206
Food & beverage: $115Education: $91
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $119 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Eisai Inc. | 1 | $16 |
Products named: LYNPARZA, IMFINZI, WELIREG, SCEMBLIX, Lenvima.
Industry payments across GA — which companies pay providers there.
